Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Similar documents
We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

Law Enforcement and the Prescriber Enforcement Action Protocol

The Wisconsin Prescription Drug Monitoring Program

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Prescribing Controlled Substances and the PDMP

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

California. Prescribing and Dispensing Profile. Research current through November 2015.

SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Curbing Prescription Drug Abuse in Medicaid

Legal Issues in Opioid Prescribing

4/10/2016. Legal & Policy Approaches to Reducing Opioid Poisonings. Overview. Background. Health Directors Legal Conference April 19, 2016

D. Todd Bess, PharmD 1

Arkansas Prescription Monitoring Program

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

Medicare Advantage Outreach and Education Bulletin

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Presentation Overview

CDC s Approach to Addressing the Opioid Overdose Epidemic

Prescription Monitoring Program (PMP)

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Model State Electronic Prescription Monitoring Program Legislation

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Liability, Informed Consent, and Risk Management 15 Thoughts for Pain Management Physicians

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Prescribing and Dispensing Drugs

Outline. Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription. Increasing community awareness of opioid risks

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016

Prescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

Illinois Heroin Crisis Act and Family Physicians. October 14, 2015 Hinsdale Family Medicine Residency Faculty Development Program

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic

THE OPIOID EPIDEMIC IN PENNSYLVANIA

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

ACCG Mental Health Summit

C. No employee shall report to work or remain on duty while having a detectable blood alcohol concentration.

& CONSUMES 80% 5% OF THE WORLD S POPULATION 5/19/2017. New Naloxone Regulations & the Importance of Using PRESCRIPTION DRUG ABUSE EPIDEMIC

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Evaluation of the N.C. Prescription

SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

White Collar Courier: Delivering News and Providing Guidance in White Collar Matters

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

Naloxone Access Statutes

Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County

Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention

Pennsylvania Prescription Drug Monitoring Program Trends,

NC General Statutes - Chapter 90 Article 5E 1

A Bill Regular Session, 2015 SENATE BILL 717

Legal Aspects of Opioid Management

Review of Controlled Drugs and Substances Act

New Policy Changes Designed to Combat the Opioid Epidemic

Addressing the Opioid Epidemic in Tennessee

University of Pittsburgh

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting

ISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.

The Role of the PDMP: Foundational Knowledge and Best Practices

PDMP Tools to Identify Red Flag Situations

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Medicare Advantage Outreach and Education Bulletin

CLINICAL POLICY Clinical Policy: Extended Release Opioid Analgesics

Report to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program

MARYLAND BOARD OF PHARMACY

TN Opioid Program. Erica Schlesinger, Pharm.D

New Guidelines for Prescribing Opioids

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

H 5381 S T A T E O F R H O D E I S L A N D

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

Arkansas Department of Health

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

HEALTH INFORMATION TECHNOLOGY: A POWERFUL TOOL IN ATTACKING THE OPIOID CRISIS PAUL L. UHRIG CHIEF ADMINISTRATIVE, LEGAL & PRIVACY OFFICER

Mental and Behavioral Health

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS)

Policy Title. Control Number HR003. Exception The Scotland County Sheriff s Department is subject to a separate policy.

SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION

POLICY ON DRUGS & ABUSE

State of California Department of Justice. Bureau of Narcotic Enforcement

Update on the Opioid Crisis

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014

Transcription:

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors This educational call is sponsored by the Enterprise Risk Management Task Force. Thursday, April 11, 2013 11:00 am 12:00 pm (Eastern Time) Presenter: Robyn Diaz St. Jude Children s Research Hospital Memphis, TN robyn.diaz@stjude.org 1

Overview Prescription Drug Abuse in the U.S. What is Doctor Shopping? Uniform Narcotic Drug Act Uniform Controlled Substances Act State Doctor Shopping Laws Prescription Monitoring Programs Managing Risks 2

Prescription Drug Abuse in the U.S. Increase in accidental opioid overdoses Prescription drug abuse increasingly common with teenagers Increasing number of overdose fatalities attributed to overprescribing 3

What is Doctor Shopping? Patient obtaining controlled substances from multiple health care practitioners without the prescribers knowledge of the other prescriptions Usually going from doctor to doctor (or to ER) in a short period of time Doctor shopping + overprescribing = dangerous combination 4

CME Requirements TN - Requires every physician to complete a 1 hour course in prescribing practices as part of mandatory 40- hour CME requirements every 2 years. OK has similar requirement to TN CA, WV both have pain management CME requirements 5

Uniform Narcotic Drug Act (1932) No person shall obtain or attempt to obtain a narcotic drug, or procure or attempt to procure the administration of a narcotic drug, (a) by fraud, deceit, misrepresentation, or subterfuge; or (b) by the forgery or alteration of a prescription ; or (c) by the concealment of a material fact; or (d) by the use of a false name or false address. (2) Information communicated to a physician in an effort unlawfully to procure a narcotic drug shall not be deemed a privileged communication. 6

Uniform Controlled Substances Act (1970) A person may not knowingly or intentionally acquire or obtain possession of a controlled substance by misrepresentation, fraud, forgery, deception, or subterfuge 7

State Doctor Shopping Laws CDC is excellent resource on state laws: http://www.cdc.gov/homeandrecreationalsafety/poisonin g/laws/dr_shopping.html Don t forget Medicaid-specific provisions 8

Look at your state law: TN Example T.C.A. 53-11-402 T.C.A. 71-5-2601 TN: Actual knowledge that a person has knowingly, willfully and with intent to deceive obtained or attempted to obtain a controlled substance -- Must report within 5 business days to local law enforcement. 9

Prescription Monitoring Programs 42 States currently have an operational PMP Pharmacists in states where monitoring programs exist are required to report controlled substance prescriptions. Prescribers may (and in some states, must) check the database before prescribing, or run regular DEA reports Alliance of States with Prescription Monitoring Programs: http://www.pmpalliance.org/ 10

TN CSMD 1/1/13 - Prescribers with DEA numbers who provide direct care to patients in Tennessee for more than 15 days per year had to register 4/1/13- Prescribers must check the database before prescribing an opioid or a benzodiazepine as a new course of treatment lasting more than 7 days, and at least annually thereafter Exceptions 11

Challenges of Databases Typically only authorized by law to run a search of your patient s information, not of a patient s family member. If you work in a multi-state/border area, you may have multiple state databases to check. Pharmacies that ship to multiple states have reporting requirements to multiple states. Operational burdens 12

Why Should Healthcare Providers be Concerned? Patient Harm Missed opportunity to treat possible addiction Liability risk (individual prescriber and institution) Reputational risk Overprescribing is of interest to law enforcement State licensing board actions (reportable to NPDB) DEA actions (reportable to NPDB) Criminal actions 13

Managing Risks Document exam and assessment before prescribing Keep good records Don t overprescribe (small quantities when possible) Discuss with patients importance of not sharing medications and of potential addiction 14

Managing Risks, Continued Look for red flags Pressure to prescribe a particular opioid Multiple increases for requests in pain meds No clear clinical explanation for pain level Rejects treatment aside from pain medications Personal or family history of substance abuse 15

Managing Risks, Continued Use pain management contract No alcohol or recreational substances Take all pain medications exactly as prescribed Do not attempt to obtain pain medications from another provider Require patient to use one pharmacy and bring bottles of pain medications to all visits Pain may be re-checked frequently Drug-screening tests? 16

Questions? 17

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors 2013 is published by the American Health Lawyers Association. All rights reserved. No part of this publication may be reproduced in any form except by prior written permission from the publisher. Printed in the United States of America. Any views or advice offered in this publication are those of its authors and should not be construed as the position of the American Health Lawyers Association. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is provided with the understanding that the publisher is not engaged in rendering legal or other professional services. If legal advice or other expert assistance is required, the services of a competent professional person should be sought from a declaration of the American Bar Association 18